Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2021 - 08 - 02 tags : Approval save search
Iridium Granted Trio of Regulatory Approvals in Japan
Published: 2021-08-02 (Crawled : 23:00) - prnewswire.com
IRDM | $27.4 5.14% 4.89% 1.6M
|
Communications
|
| O: 1.19%
H: 0.33%
C: -2.07%
approval granted grant
Kantara Approves LexisNexis® Risk Solutions Risk Defense Platform Compliance with NIST SP 800-63 rev.3 (Technical) Class of Approval, as a Component Service at IAL2
Published: 2021-08-02 (Crawled : 17:00) - biospace.com/
RELX | $41.07 -0.87% 0.0% 1.1M
|
Commercial Services
|
| O: -0.98%
H: 1.09%
C: 0.51%
defense risk approval
Global Bispecific Antibody Therapeutics Market Forecast Clinical Trials Drug Approval Insight 2028
Published: 2021-08-02 (Crawled : 15:00) - prnewswire.com
ARVL | News | $0.49 0.37% 2.5M
|
Manufacturing
|
| O: 0.15%
H: 1.54%
C: -1.38%
clinical trials antibody drug trial approval
Arcturus Announces Approval of a Clinical Trial Application to Advance ARCT-154, a Next Generation STARR™ mRNA Vaccine Targeting the SARS-CoV-2 Delta Variant and Other Variants of Concern
Published: 2021-08-02 (Crawled : 14:00) - biospace.com/
TAK | News | $13.24 0.61% 0.0% 1.3M
|
Health Technology
|
| O: -0.36%
H: 0.75%
C: -0.18%
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: 0.02%
H: 0.21%
C: -0.12%
ARCT 4 | $25.995 -1.23% -1.25% 630K
|
Health Technology
|
| O: 6.36%
H: 9.92%
C: 5.16%
vaccine trial approval sars-cov-2
VYNE Therapeutics Announces Approval of AMZEEQ® (Minocycline) and ZILXI® (Minocycline) in Chinese Economic Pilot Zone
Published: 2021-08-02 (Crawled : 13:00) - vynetherapeutics.com
VYNE | $2.285 -0.65% -0.66% 19K
|
Health Technology
|
| O: 1.1%
H: 4.0%
C: 0.0%
chinese approval
Lupus Research Alliance Applauds U.S. FDA Approval of AstraZeneca's anifrolumab-fnia (Saphnelo™) for Systemic Lupus Erythematosus (SLE)
Published: 2021-08-02 (Crawled : 12:00) - biospace.com/
AZN | News | $68.56 0.29% 0.29% 4.7M
|
Health Technology
|
| O: -0.7%
H: 0.86%
C: 0.58%
fda fda approval research approval lupus
Amicus Therapeutics Announces European Commission Approval of Galafold® (migalastat) for Adolescents with Fabry Disease
Published: 2021-08-02 (Crawled : 12:00) - biospace.com/
FOLD F | $10.62 2.81% 2.73% 2.5M
|
Health Technology
|
| O: 0.16%
H: 1.72%
C: 1.29%
disease europe approval
Ecopetrol S.A. obtains approval for a contingent line of credit for up to US$ 1,200 million
Published: 2021-08-02 (Crawled : 11:00) - prnewswire.com
EC | News | $11.51 1.5% -0.09% 1.4M
|
Energy Minerals
|
| O: 0.29%
H: 1.13%
C: -2.86%
SAN | $4.75 0.0% 3M
|
Finance
|
| O: -0.54%
H: 1.36%
C: -1.08%
approval
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
Your saved searches
Save your searches and get alerts when important news are released.